We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience. You can read our Cookie Policy here.

Advertisement
Promega ViaFect™ Transfection Reagent Delivers High Performance Transfection Across Multiple Cell Lines, Including iPS Cells
Product News

Promega ViaFect™ Transfection Reagent Delivers High Performance Transfection Across Multiple Cell Lines, Including iPS Cells

Promega ViaFect™ Transfection Reagent Delivers High Performance Transfection Across Multiple Cell Lines, Including iPS Cells
Product News

Promega ViaFect™ Transfection Reagent Delivers High Performance Transfection Across Multiple Cell Lines, Including iPS Cells


Want a FREE PDF version of This Product News?

Complete the form below and we will email you a PDF version of "Promega ViaFect™ Transfection Reagent Delivers High Performance Transfection Across Multiple Cell Lines, Including iPS Cells"

First Name*
Last Name*
Email Address*
Country*
Company Type*
Job Function*
Would you like to receive further email communication from Technology Networks?

Technology Networks Ltd. needs the contact information you provide to us to contact you about our products and services. You may unsubscribe from these communications at any time. For information on how to unsubscribe, as well as our privacy practices and commitment to protecting your privacy, check out our Privacy Policy

Promega Corporation announces ViaFect™ Transfection Reagent, a tool for efficient DNA transfer into a wide variety of cell lines, including challenging suspension cells and stem cell-derived lines. ViaFect Transfection Reagent allows researchers to develop transfection-based assays in the cell line most relevant for their biology of interest.

Induced pluripotent stem cell (iPSC)-derived cell models, such as Cellular Dynamics International's iCell® Cardiomyocytes, show robust transfection with ViaFect Transfection Reagent, enabling assays not possible with other reagents.

This low toxicity reagent allows cells to stay healthy and metabolically active during transfection-based experiments, even at low cell densities, facilitating experiments where extended application of a treatment is needed. Cell viabilities of greater than 90% are routinely observed following transfection with ViaFect Transfection Reagent.

ViaFect Transfection Reagent requires minimal optimization with a simple three-step protocol. It does not require removal of serum, removal of culture medium or washing after introduction of the reagent/DNA complex. ViaFect Transfection Reagent contains no animal-derived components. 

A poster detailing results using ViaFect Transfection Reagent will also be presented at the Society for Laboratory Automation and Screening Conference and Exhibition to be held January 18th-22nd in San Diego, CA.

Advertisement